Shenzhen Geno-Immune Medical Institute

The Faculty of Medicine Siriraj Hospital, Mahidol University, and the Shenzhen Geno-immune Medical Institute in China have established a Memorandum of Understanding (MoU) centered around the “Technology Transfer and Application on Chimeric Antigen Receptor T-Cell (CAR-T) Therapy and Gene Therapy.” This collaborative agreement encompasses various initiatives, including medical staff exchange programs, aimed at facilitating the clinical utilization of CAR T cells. The ultimate objective is to introduce CAR T cell therapy as a treatment option for cancer patients in Thailand.